• 1
    Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidol 1996; 7: 21726.
  • 2
    WHO. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO consultation on obesity. Geneva: WHO, 1998.
  • 3
    Laakso M, Sarlund H & Salonen R et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Throm 1991; 11: 106876.
  • 4
    Agewall S, Fagerberg B, Attwall S, Wendelhag I, Urbanavicius V & Wikstrand J. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke 1995; 26: 95660.
  • 5
    Bressler P, Bailey SR, Matsuda M & DeFronzo RA. Insulin resistance and coronary artery disease. Diabetologia 1996; 39: 134550.DOI: 10.1007/s001250050581
  • 6
    Howard GO, O'leary D & Zaccaro D et al. Insulin sensitivity and atherosclerosis. Circulation 1996; 93: 180917.
  • 7
    Bonora E, Tessari R & Micciolo R, et al. Intima-medial thickness of the carotid artery in nondiabetic and NIDDM Subjects. Diabetes Care 1997; 4: 62731.
  • 8
    Suzuki M, Shinozaki K & Kanazawa A et al. Insulin resistance as an independent risk factor for carotid wall thickening. Hypertension 1996; 28: 59398.
  • 9
    Kekäläinen P, Sarlund H, Farin P, Kaukanen E, Yang X & Laakso M. Femoral atherosclerosis in middle-aged subjects: association with cardiovascular risk factors and insulin resistance. Am J Epidemiol 1996; 8: 74248.
  • 10
    Lithell H. Metabolic aspects of the treatment of hypertension. J Hypertens 1995; 13: S7780.
  • 11
    Agewall S, Fagerberg B & Samuelsson O, et al. Multiple cardiovascular risk factor intervention in treated hypertensive men: what can be achieved? Nutr Metab Cardiovasc Dis 1993; 3: 12835.
  • 12
    Zanchetti A, Chalmers J & Corvol P et al. Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1989; 7: 68993.
  • 13
    Bokemark L, Frödén A, Attvall S, Wikstrand J & Fagerberg B. The euglycemic hyperinsulinemic clamp examination: variability and reproducibility. Scand J Clin Lab Invest 2000; 60: 2736.
  • 14
    Pietrobelli A, Formica C, Wang Z & Heymsfield SB. Dual-energy X-ray absorptiometry body composition model: review of physical concepts. Am J Physiology 1996; 271 (Endocrinol Metab 34): E94151.
  • 15
    Schmidt C & Wendelhag I. How can the variability in ultrasound measurement of intima-media thickness be reduced? Studies of interobserver variability in carotid and femoral arteries. Clin Physiol 1999; 19: 4555.DOI: 10.1046/j.1365-2281.1999.00145.x
  • 16
    Suurküla M, Agewall S, Fagerberg B, Wendelhag I, Widgren B & Wikstrand J. Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Arterioscler Thromb 1994; 14: 1297304.
  • 17
    Klose S & Borner K. Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA-II). J Clin Chem Clin Biochem 1978; 15: 12130.
  • 18
    Wahlefeld AW. Triglycerides: determination after enxymatic hydrolysis. In: BermeyerHU, ed. Methods of Enxymatic Analysis, 2nd edn. New York: Academic Press, 1974; 1831.
  • 19
    Friedewald WT, Levy RI & Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499502.
  • 20
    Hulthe J, Wiklund O & Olsson G et al. Computerized measurement of LDL particle size in human serum. Scan J Clin Lab Invest 1999; 59: 113.
  • 21
    Thornvall P, Båvenholm P, Landou C, De Faire U & Hamsten A. Relation of plasma levels and composition of apolipoprotein B-containing lipoporoteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 1993; 88: 218089.
  • 22
    Haffner SD, D'agostino R & Saad M, et al. Increased insulin resistance and insulin secretion in non-diabetic African-Americans, and Hispanics compared to non-Hispanic whites: The Insulin Resistance Atherosclerosis Study. Diabetes 1996; 45: 74248.
  • 23
    Muller DC, Elahi D, Tobin JD & Andres R. The effect of age on insulin resistance and secretion: a review. Semin Nephrol 1996; 16: 28998.
  • 24
    Yki-Jarvinen H, Sammalkorpi K, Koivisto VA & Nikkila EA. Severity, duration and mechanisms of insulin resistance during acute infections. J Clin Endocrinol Metab 1989; 69: 31723.
  • 25
    Bergman RN, Finegood DT & Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985; 6: 4586.
  • 26
    Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N & Mingrone G on behalf of the European Group for the Study of Insulin resistance (EGIR). Insulin resistance and hypersecretion in obesity. J Clin Invest 1997; 100: 116673.
  • 27
    Berglund L & Lithell H. Prediction models for insulin resistance. Blood Press 1996; 5: 27477.
  • 28
    O'leary D, Polak J, Kronmal R, Manolio T, Burke G & Wolfson S Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 1422.
  • 29
    O'leary D, Polak J & Kronmal R. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 1992; 23: 175260.
  • 30
    Mannami T, Konishi M, Baba S, Nishi N & Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke 1997; 28: 51825.
  • 31
    Bots M, Breslau P & Briet E. Cardiovascular determinants of carotid artery disease: the Rotterdam Elderly Study. Hypertension 1992; 19: 71720.
  • 32
    Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, De Feyter PJ & Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke 1997; 28: 118994.
  • 33
    Burke G, Evans G & Riley W. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1995; 26: 38691.
  • 34
    Allan P, Mowbray P, Lee A & Fowkes F. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease: the Edinburgh Artery Study. Stroke 1997; 28: 34853.
  • 35
    Haffner S & Miettinen H. Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med 1997; 103: 15262.DOI: 10.1016/s0002-9343(97)00027-2
  • 36
    Salonen J & Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11: 124549.
  • 37
    Bots M, Hoes A, Koudstaal P, Hofman A & Grobbee D. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96: 143237.
  • 38
    Chambless L, Heiss G & Folsom A. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study 1987–1993. Am J Epidemiol 1997; 146: 48394.
  • 39
    Hodis H, Mack W & LaBree L. The role of carotid artery intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 26269.